InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by GORDON CARL L, Director. Insider active across 4 companies, notably Theseus Pharmaceuticals, Inc.. Aggregated, 13 disclosures have been published. Total volume traded: €12.5m. The latest transaction was disclosed on 11 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations13 total
€110,16764,700 shares@ €1.70270.033% mcap1.0% of flow
Common Stock
SEC:0000947871-22-000568:0·
Ideal exit: 5 Feb 2023 (T+270)
€15,77510,200 shares@ €1.54650.0047% mcap0.1% of flow
Common Stock
SEC:0000947871-22-000539:0·
Ideal exit: 31 Jan 2023 (T+270)
€1m156,000 shares@ €8.9527100.0% of flow
Common Stock
SEC:0000947871-22-000255:0·
Ideal exit: 8 Nov 2022 (T+270)
€101,38411,521 shares@ €8.799988.0% of flow
Common Stock
SEC:0000947871-22-000088·
Ideal exit: 16 Oct 2022 (T+270)
€101,38411,521 shares@ €8.799944.0% of flow
Common Stock
SEC:0000947871-22-000088:0·
Ideal exit: 16 Oct 2022 (T+270)
€13,8531,600 shares@ €8.658112.0% of flow
Common Stock
SEC:0000947871-22-000050·
Ideal exit: 8 Oct 2022 (T+270)
€13,8531,600 shares@ €8.65816.0% of flow
Common Stock
SEC:0000947871-22-000050:0·
Ideal exit: 8 Oct 2022 (T+270)
€3m214,285 shares@ €12.39673.29% mcap100.0% of flow
Common Stock
SEC:0000947871-21-001281·
€3m214,285 shares@ €12.39673.29% mcap50.0% of flow
Common Stock
SEC:0000947871-21-001281:0·
€5m1,785,715 shares@ €3.0132100.0% of flow
Common Stock
SEC:0000947871-21-001151·
Ideal exit: 1 Aug 2022 (T+270)
€5m1,785,715 shares@ €3.01321.61% mcap49.4% of flow
Common Stock
SEC:0000947871-21-001151:0·
Ideal exit: 1 Aug 2022 (T+270)
15,777,018 shares
Common Stock
SEC:0000899243-21-040256·
15,777,018 shares
Common Stock
SEC:0000899243-21-040256:0·
13 of 13 declarations
About GORDON CARL L
Carl L. Gordon is a Board Member at Theseus Pharmaceuticals, Inc., Compass Therapeutics, Inc., and Adicet Bio, Inc. He brings his expertise in biotechnology and corporate strategy, contributing to the governance of these companies. Gordon plays a key role in defining strategic directions and overseeing operations.
